Trial Profile
A Study Comparing The Severity Of Sleep Disorders In Chronic Hepatitis C Patients Treated With Interferon-Based Therapy and Direct-Acting Antiviral (DAA) Therapy Using Actigraphy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2017
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Peginterferon (Primary) ; Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2017 New trial record
- 01 Dec 2016 Results published in the Hepatology Research journal.